Navigation Links
Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results
Date:10/25/2011

xchange rates used to convert transactions in foreign currencies (primarily the Euro, British pound sterling and Chinese yuan) to U.S. dollars and,
  • the acquisitions of Boston Biochem, Inc. on April 1, 2011 and Tocris Holdings, Ltd on April 28, 2011, including the impact of amortizing intangible assets and the recognition of costs upon the sale of inventory written-up to fair value.

  • These adjusted financial measures are not prepared in accordance with generally accepted accounting principles (GAAP) and may be different from adjusted financial measures used by other companies.  Adjusted financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.  We view these adjusted financial measures to be helpful in assessing the Company's ongoing operating results.  In addition, these adjusted financial measures facilitate our internal comparisons to historical operating results and comparisons to competitors' operating results.  We include these adjusted financial measures in our earnings announcement because we believe they are useful to investors in allowing for greater transparency related to supplemental information we use in our financial and operational analysis. Investors are encouraged to review the reconciliations of adjusted financial measures used in this press release to their most directly comparable GAAP financial measures as provided with the financial statements attached to this press release.

    Techne Corporation has two operating subsidiaries:  Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England.  R&D Systems is a specialty manufacturer of biological products.  R&D Systems has four subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California, Boston Biochem, Inc., located in Cambridge,
    '/>"/>

    SOURCE Techne Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Techne Corporation Declares Dividend
    2. Techne Corporation Declares Dividend
    3. Technest Holdings, Inc. to Acquire AccelPath, LLC; Issue Contingent Value Rights to Common Stockholders; and Issue Shares of Its Series E 5% Convertible Preferred Stock
    4. Techne Corporation Releases Unaudited Fourth Quarter and Fiscal Year 2011 Results
    5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
    6. CEL-SCI Corporation Releases Letter to Shareholders
    7. Alfacell Corporation to Present at UBS Global Life Sciences Conference
    8. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
    9. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
    10. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
    11. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... , March 3, 2015  3-D printing could ... treatments to individual patient needs, with clinicians having ... size and shape. That,s according to a study ... Radiology ,s Annual Scientific Meeting . Researchers ... filaments that were bioactive, giving these devices the ...
    (Date:3/3/2015)... March 3, 2015  KaVo Kerr Group, a global ... new products at the 36 th International Dental ... Kerr Group delivers products and solutions to 99% of ... trade fair for the dental industry — the ideal ... to offer. The meeting, March 10-14, 2015, expects more ...
    (Date:3/3/2015)... 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announces ... Executive Officer, will be making a corporate presentation at ... 8-11 in Dana Point, CA.  Dr. Ren will present ...
    Breaking Medicine Technology:3-D printing offers innovative method to deliver medication 23-D printing offers innovative method to deliver medication 33-D printing offers innovative method to deliver medication 4KaVo Kerr Group Prepares to Present 35+ New Products at the 36th IDS in Cologne 2KaVo Kerr Group Prepares to Present 35+ New Products at the 36th IDS in Cologne 3CASI Pharmaceuticals To Present At The 27th Annual ROTH Conference 2
    ... OXIS International, Inc., (OTC Bulletin Board: OXIS ... Executive Officer, and Bernie Landes, President, will present to ... Sciences & Medical Technologies On-Line Forum on Thursday, February ... A webcast of the presentation will be ...
    ... Hardy Diagnostics, an ISO certified biomedical firm, is pleased ... selective chromogenic medium recommended for use as a primary ... Salmonella and Shigella spp. from stool ... non-pathogenic enteric bacteria based on colony color. Differentiation of ...
    Cached Medicine Technology:The Only Chromogenic Medium That Detects Both Salmonella and Shigella! 2
    (Date:3/3/2015)... 2015 Raritan Bay Medical Center is ... an interactive photo contest held at the Woodbridge Center ... To raise awareness for health and wellness in the ... their best health and wellness tips. , Photos of ... Center’s website and Facebook page where Facebook users voted ...
    (Date:3/3/2015)... (PRWEB) March 03, 2015 Claflin ... the Department of Veterans Affairs has signed a new, ... March 1, 2015. , Under the contract, the ... such as the U.S. Military, Indian Health Services, National ... local government entities with competitive pricing for hospital equipment ...
    (Date:3/3/2015)... A newly launched program is available ... II diabetes, and pre-diabetes. As opposed to traditional pharmaceutical ... for diabetes sufferers to reverse their disease without the ... In 2013, the U.S. diabetes industry made $250 billion ... include the use of insulin and other glucose-controlling medications ...
    (Date:3/3/2015)... T-System Inc. today announced ... CPHQ, FABC as the company’s chief nursing officer along ... episodic care. , “Today’s patients are demanding ... including urgent care and freestanding emergency centers one of ... Davis, T-System’s chief executive officer. “We have a ...
    (Date:3/3/2015)... March 03, 2015 The Data 360 ... at the Ford Conference Center, Dearborn, MI, on March 5, ... Inc., is a featured speaker. He is known internationally as ... , These designations were earned due to years of ... commercially-available NoSQL DB, released over 10 years ago. Subsequent developments ...
    Breaking Medicine News(10 mins):Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4
    ... looking into Tamiflu; Relenza also under scrutiny. , , ... Food and Drug Administration panel is meeting Tuesday ... flu drug Tamiflu (oseltamivir), linked recently to anecdotal ... , The FDA,s Pediatric Advisory Committee will begin ...
    ... STORZ OR1(R) GIVES SURGEONS, GREATER ACCESS TO PATIENT DATA AND ... ... REMOTELY, ALISO VIEJO, Calif., Nov. 27 Global Care Quest, ... Inc., the world leader in minimally invasive,endoscopic technologies and operating room integration, ...
    ... Nov. 27 Merge Healthcare (Nasdaq:,MRGE; TSX: ... services provider,announced today that its Merge Healthcare ... Gold Seal of Approval(TM), by demonstrating,compliance with ... national standard for healthcare quality and safety. ...
    ... million Series A financing from Alta Partners, ... ProQuest Investments and RiverVest Venture Partners, CARLSBAD, ... Pharmaceuticals, Inc. (Nasdaq: ISIS ) and Excaliard ... and develop antisense,drugs for the local treatment of ...
    ... green product design granted the International HIDO ... Award, TORONTO, and GOLFE JUAN, France, Nov. ... specializing in sustainable and health,product innovations and HIDO, ... has received the HIDO,International Design Award. The Award ...
    ... MAR, Calif., Nov. 27 ,Awake, the movie is a,psychological ... awareness" and finds himself awake and aware, but paralyzed,during heart ... ,Coma, captured and terrified,the American public,s imagination. ,Coma, is the ... surgery -- and never wake up again., "Five years ...
    Cached Medicine News:Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 2Health News:FDA Mulls Tougher Warning Label on Kids' Flu Drugs 3Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 2Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 3Health News:Merge Healthcare Teleradiology Division Receives Accreditation From Joint Commission 2Health News:Merge Healthcare Teleradiology Division Receives Accreditation From Joint Commission 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 2Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 3Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 4Health News:Isis and Excaliard Collaborate to Develop Antisense Drugs for Local Treatment of Fibrotic Diseases 5Health News:Cooler Solutions' 'Dignity Toilet' Wins International Design Competition by Providing Sanitation for Those in Need 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 2Health News:'Awake' the Movie Highlights the Need for 'Goldilocks' Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R) 3
    ... Oxygen Conservation Device. Bypass ... ,6200 Accessories: , OCD870C ... CGA 540 Regulator , OCD2001-18 ... Booklet , CP2140 Vertical M-6 ...
    ... with Accutrol is similar in design to ... it incorporates a temperature probe at the ... probe can accurately determine the patient's core ... temperature accuracy comparable to a pulmonary artery ...
    ... These markers are available with 16 or 24 circular ... diameter, and an outer 9.5mm diameter. The markers are ... one single step for a 16 or 24 running ... points on the cornea to achieve a precise and ...
    ... Shafts For Insertion Through A 1.0mm Incision., ... ... A More Comfortable Approach., ,Recessed Jaws For ... For Protection Of Jaws During Sterilization., ,Reusable, ...
    Medicine Products: